Mitsubishi Ufj Asset Management Co., Ltd. / ABT
Mitsubishi Ufj Asset Management Co., Ltd.’s Abbott Laboratories Position
Does Mitsubishi Ufj Asset Management Co., Ltd. own Abbott Laboratories (ABT)? Yes — 4.91M shares worth $505M (+0.34% of its 13F portfolio) as of Q1 2026, down from 7.00M shares the prior filed quarter.
Position Value
$505M
Q1 2026
Shares
4.91M
% of Portfolio
+0.34%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 4.91M | $505M | +0.34% |
| Q4 2025 | 7.00M | $869M | +0.59% |
| Q3 2025 | 6.90M | $924M | +0.67% |
| Q2 2025 | 5.96M | $811M | +0.65% |
| Q1 2025 | 6.52M | $865M | +0.80% |
| Q4 2024 | 7.34M | $835M | +0.81% |
| Q3 2024 | 6.99M | $797M | +0.85% |
| Q2 2024 | 6.71M | $697M | +0.85% |
| Q1 2024 | 6.35M | $722M | +1.00% |
| Q4 2023 | 5.90M | $646M | +1.14% |
| Q3 2023 | 5.63M | $545M | +1.10% |
| Q2 2023 | 5.39M | $587M | +1.23% |
| Q1 2023 | 5.19M | $525M | +1.25% |
| Q4 2022 | 4.91M | $538M | +1.47% |
| Q3 2022 | 4.58M | $443M | +1.43% |
| Q2 2022 | 1.04M | $113M | +0.50% |
| Q1 2022 | 973.1K | $115M | +0.46% |
| Q4 2021 | 894.9K | $124M | +0.49% |
| Q3 2021 | 791.1K | $93M | +0.46% |
| Q2 2021 | 726.3K | $84M | +0.46% |
| Q1 2021 | 645.3K | $77M | +0.51% |
| Q4 2020 | 584.5K | $64M | +0.49% |
| Q3 2020 | 553.6K | $60M | +0.55% |
| Q2 2020 | 457.9K | $42M | +0.48% |
| Q1 2020 | 420.6K | $33M | +0.51% |
| Q4 2019 | 398.5K | $34M | +0.45% |
| Q3 2019 | 311.9K | $26M | +0.42% |
| Q2 2019 | 298.9K | $25M | +0.43% |
| Q1 2019 | 237.6K | $19M | +0.39% |
| Q4 2018 | 221.9K | $15M | +0.37% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mitsubishi Ufj Asset Management Co., Ltd.’s full portfolio or all institutional holders of ABT.